Mycoplasma genitalium is a newly-described but well established STI pathogen with clinical manifestations very similar to those caused by Chlamydia trachomatis. Island Health is now testing for M. genitalium routinely.
In males it causes acute and persistent urethritis. In females it is usually asymptomatic but may cause cervicitis and/or PID. It is also associated with infertility and adverse pregnancy outcomes.
Island Health is now utilizing a molecular assay that tests for four STI pathogens on all samples that request testing for any STI pathogen. All requests for Chlamydia trachomatis and/or Neisseria gonorrhoea and/or Trichomonas vaginalis and/or Mycoplasma genitalium will result in testing for all four pathogens. The new combined assay will be referred to as the STI Pathogen Panel and this is now the preferred order.